Literature DB >> 27929206

Acute Bronchitis.

Scott Kinkade1, Natalie A Long1.   

Abstract

Cough is the most common illness-related reason for ambulatory care visits in the United States. Acute bronchitis is a clinical diagnosis characterized by cough due to acute inflammation of the trachea and large airways without evidence of pneumonia. Pneumonia should be suspected in patients with tachypnea, tachycardia, dyspnea, or lung findings suggestive of pneumonia, and radiography is warranted. Pertussis should be suspected in patients with cough persisting for more than two weeks that is accompanied by symptoms such as paroxysmal cough, whooping cough, and post-tussive emesis, or recent pertussis exposure. The cough associated with acute bronchitis typically lasts about two to three weeks, and this should be emphasized with patients. Acute bronchitis is usually caused by viruses, and antibiotics are not indicated in patients without chronic lung disease. Antibiotics have been shown to provide only minimal benefit, reducing the cough or illness by about half a day, and have adverse effects, including allergic reactions, nausea and vomiting, and Clostridium difficile infection. Evaluation and treatment of bronchitis include ruling out secondary causes for cough, such as pneumonia; educating patients about the natural course of the disease; and recommending symptomatic treatment and avoidance of unnecessary antibiotic use. Strategies to reduce inappropriate antibiotic use include delayed prescriptions, patient education, and calling the infection a chest cold.

Entities:  

Mesh:

Year:  2016        PMID: 27929206

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  14 in total

1.  Patient and provider characteristics and outcomes associated with outpatient antibiotic overuse in acute adult bronchitis.

Authors:  Diana Li; Maricar Conson; Nina Kim; Marie Yasuda; Delaney Ivy; Sandy Diec; Paul Godley
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-02-03

2.  Audit and Feedback: A Quality Improvement Study to Improve Antimicrobial Stewardship.

Authors:  Ryan G Pett; Francisco Silva; Colleen D'Amico
Journal:  Fed Pract       Date:  2021-06

3.  Variability of Antibiotic Prescribing in a Large Healthcare Network Despite Adjusting for Patient-Mix: Reconsidering Targets for Improved Prescribing.

Authors:  Sophia Jung; Mary Elizabeth Sexton; Sallie Owens; Nathan Spell; Scott Fridkin
Journal:  Open Forum Infect Dis       Date:  2019-01-18       Impact factor: 3.835

4.  Low Uptake of Rapid Diagnostic Tests for Respiratory Tract Infections in an Urban Safety Net Hospital.

Authors:  Shana A B Burrowes; Alec Rader; Pengsheng Ni; Mari-Lynn Drainoni; Tamar F Barlam
Journal:  Open Forum Infect Dis       Date:  2020-03-03       Impact factor: 3.835

5.  Changes in children's respiratory morbidity and residential exposure factors over 25 years in Chongqing, China.

Authors:  Yueyue Li; Xin Huang; Qin Liu; Wenyan Li; Bo Yang; Yiwen Chen; Weiwei Lin; Junfeng Jim Zhang
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 3.005

6.  The safety and efficacy of CKD-497 in patients with acute upper respiratory tract infection and bronchitis symptoms: a multicenter, double-blind, double-dummy, randomized, controlled, phase II clinical trial.

Authors:  Seung Won Ra; Sun Young Kim; Yun Young Lim; Shin Jung Park; Chin Kook Rhee; Deog Kyeom Kim; Yong Bum Park; Chang Youl Lee; Hyoung Kyu Yoon; Jeong-Woong Park; Kwang Ha Yoo
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 3.005

7.  Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China.

Authors:  Xiaodong Guan; Luwen Shi; Mengyuan Fu; Haishaerjiang Wushouer; Lin Hu; Nan Li; Dennis Ross-Degnan
Journal:  NPJ Prim Care Respir Med       Date:  2021-05-10       Impact factor: 2.871

8.  Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony-stimulating factor as support to chemotherapy for lung cancer.

Authors:  Xiang Ji; Lisheng Xu; Pengfei Pan; Zhiyun Xu; Aihua Wang; Yu Li
Journal:  Thorac Cancer       Date:  2021-11-17       Impact factor: 3.500

9.  Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial.

Authors:  Yee Ran Lyu; Won-Kyung Yang; So Jung Park; Seung-Hyeong Kim; Wee-Chang Kang; In Chul Jung; Yang Chun Park
Journal:  BMJ Open       Date:  2018-05-14       Impact factor: 2.692

Review 10.  The Spectrum of Non-asthmatic Airway Diseases Contributing to Cough in the Adult.

Authors:  Sidney S Braman; Armeen Poor
Journal:  Curr Otorhinolaryngol Rep       Date:  2019-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.